The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.

We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Legislation that would block hospitals from transfusing blood containing COVID-19 antibodies or “synthetic mRNA” would ...

Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...

Polk County’s level of immunization for kindergartners dropped from 96.3% in 2021 to 93.2% in 2023, still above the statewide ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

President Donald Trump is hitting the ground running, having signed more than two dozen executive orders and memoranda since ...

A businessman is offering $1 million prize to anyone who can prove the mRNA COVID-19 inoculations did not kill more people ...

The expression of genes has to be carefully regulated in cells; active genes give cells their identity and ability to function... | Cell And Molecular Biology ...